Photo via NBC News

New prostate cancer screening guidelines include regular PSA testing for most older men

Read the original at NBC News ↗
Cite

Ryan, B. (2026, November 12). New prostate cancer screening guidelines include regular PSA testing for most older men. NBC News. https://www.nbcnews.com/health/cancer/new-prostate-cancer-screening-guidelines-regular-psa-test-rcna608629

Dated from the outlet's own feed. Check the original for its byline.

NBC News · collected 2026-11-12 · by Benjamin Ryan

Quick Summary

The American Cancer Society published new guidelines on Thursday recommending that most men ages 50 to 69 receive prostate-specific antigen (PSA) blood tests every other year. The guidelines specify that Black men and those with a significant family history of the disease should receive annual screenings starting at age 45, while men aged 70 to 74 should consult providers regarding the test's suitability based on life expectancy. This report highlights a shift toward more emphatic screening recommendations for average-risk men, driven by a two-decade European study confirming that screening reduces cancer deaths even as the decline in death rates has recently stabilized.
Written by AI on 2026-11-13, from this article's own text only (the story summary below draws on all the coverage).
See how they differ ↓

AI analysis

Story summary

The American Cancer Society has updated its guidelines to recommend regular prostate cancer screening for men aged 50 to 69, starting twice every year. For those at higher risk, including those with a family history of prostate cancer, screening should begin at age 45. This change reflects the growing evidence supporting the benefits of PSA (prostate-specific antigen) blood tests, which can detect early signs of prostate cancer. The new guidelines aim to address the second most common cause of cancer deaths in U.S. men, with an estimated 36,000 deaths and 333,000 cases annually. The update comes as prostate cancer diagnoses are on the rise, and experts emphasize the need for early detection to improve outcomes.

Written for “Prostate Cancer Screening Guidelines Updated” on 2026-11-21, grounded in this article and the 10 other(s) covering the same event.

How they differ

8 outlets covered “Prostate Cancer Screening Guidelines Updated”.

What each outlet says

One AI summary per outlet of its latest article on this story, written from that article alone and checked against it. Open the article for the outlet's own words.

NBC NewsThis outlet12 Nov

The American Cancer Society published new guidelines on Thursday recommending that most men ages 50 to 69 receive prostate-specific antigen (PSA) blood tests every other year. The guidelines specify that Black men and those with a significant family history of the disease should receive annual screenings starting at age 45, while men aged 70 to 74 should consult providers regarding the test's suitability based on…

New prostate cancer screening guidelines include regular PSA testing for most older men (this article)2 articles from NBC News on this story
New York Post12 Nov

The American Cancer Society has updated its prostate cancer screening guidelines for men aged 50 to 69, recommending PSA tests every two years for those at average risk, and annually for Black men or those with a family history of the disease starting at age 45. This marks a significant shift from previous guidance, which advised patients to decide with their doctors whether to screen. The new recommendations are…

New prostate cancer screening guidelines mean changes for men over 50: what to know →
The Independent12 Nov

The American Cancer Society has issued new guidelines recommending that most men aged 50-69 receive a prostate-specific antigen (PSA) blood test every other year, while high-risk groups like Black men and those with a family history should begin screening at age 45. The updated guidance is based on evidence that these tests significantly reduce mortality and advanced-stage diagnoses, including a 2025 European study…

New guidance issued for prostate cancer screening in the US: Here is what you need to know →
CBC12 Nov

The American Cancer Society recently updated its guidelines, now recommending that men at average risk of prostate cancer start getting PSA tests every two years from age 50 to 69, while high-risk men should begin yearly testing at age 45. In Canada, however, guidelines have not been updated since 2014 and do not recommend routine PSA testing due to concerns about false positives and unnecessary biopsies. Canadian…

The U.S. is now urging middle-aged men to routinely screen for prostate cancer. What about Canada? →
Show 2 more outlets
Washington Examiner12 Nov

The American Cancer Society is issuing new guidance recommending more frequent prostate cancer blood test screenings as diagnoses of the disease rise nationwide. Men between the ages of 50 and 69 are advised to be tested every other year, while higher-risk individuals—specifically Black men and those with family histories of the disease—should receive annual screenings. The report highlights a shift toward more…

Doctors encourage prostate cancer blood test for younger men →
Fox News14 Nov

The American Cancer Society has released new guidelines recommending that men at average risk start regular prostate cancer screening at age 50, with PSA tests every two years for men aged 50 to 69. For Black men and those with a family history of prostate cancer, the recommendation is to begin annual screenings at age 45. Dr. Ash Tewari emphasizes the high success rate of treating prostate cancer if caught early…

New prostate cancer guidelines urge men to start screening at specific age →

Where they agree and split

Framing

How the first headlines put it

Stated as fact7
The headlines (7)

New prostate cancer screening guidelines include regular PSA testing for most older men NBC News · stated as fact

New prostate cancer screening guidelines mean changes for men over 50: what to know New York Post · stated as fact

How men can guard against prostate cancer CBS News · stated as fact

New guidance issued for prostate cancer screening in the US: Here is what you need to know The Independent · stated as fact

New U.S. guideline urges routine prostate cancer screening for middle-aged men Toronto Star · stated as fact

The U.S. is now urging middle-aged men to routinely screen for prostate cancer. What about Canada? CBC · stated as fact

Doctors encourage prostate cancer blood test for younger men Washington Examiner · stated as fact

The full story: what happened, how it changed, and all 11 articles →

Compared with similar articles

This article reads unscored and hedges 10% of its claims. Each row says how that neighbour differs.
CBS News
Hedges 6 of 27 claims Outlet record 66/100
NBC News
Hedges 1 of 4 claims Outlet record 74/100
Fox News
Hedges 2 of 32 claims Outlet record 66/100
Washington Examiner
Hedges 1 of 2 claims Outlet record 67/100
The Independent
Hedges 6 of 24 claims Outlet record 59/100
New York Post
Hedges 3 of 29 claims Outlet record 66/100
Toronto Star
Hedges 0 of 2 claims Outlet record 65/100
CBS News
Hedges 1 of 2 claims Outlet record 66/100
CBS News
Hedges 0 of 2 claims Outlet record 66/100

Story

Prostate Cancer Screening Guidelines Updated
Health · 11 article(s) covering the same event. Compare every outlet's account →
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
48
sentences that state something as happening or true
Uncertain
10%
5 of 48 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
74/100
NBC News's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
11
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-11-13 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

NBC News · 2732 article(s) · 5 correction(s) detected
Running correction rate · 5 correction(s)

Who wrote this

Benjamin Ryan
1 article(s) here · 1 carrying a prediction
Dr. William L. Dahut, chief scientific officer of the ACS, said he hoped the new guidelines “would increase screening for men at average risk and ultimately lead to a decrease of men with metastatic disease or dying from the disease, while mitigating harm.”
The only article under this byline in the corpus.

Topics

ACS Black CA: The Food and Drug Administration the American Cancer Society

Subjects

ACS ORG · 6× Black NORP · 1× CA: ORG · 1× Dahut PERSON · 1× The Food and Drug Administration ORG · 1× U.S. Preventive Services Task Force ORG · 1× William L. Dahut PERSON · 1× the American Cancer Society ORG · 1×

Narrative

Annual screening starting at age 45 is advised for two higher-risk groups: - Black men, who have higher rates of prostate cancer and are likelier to die from it. - Men who have fathers or brothers diagnosed under age 65 or who have multiple such relatives diagnosed at any age. The PSA blood test can help detect signs of prostate cancer earlier, when it’s generally more susceptible to treatment.
framing: assertive · carried by 1 article(s) · first seen 2026-11-13
Dr. William L. Dahut, chief scientific officer of the ACS, said he hoped the new guidelines “would increase screening for men at average risk and ultimately lead to a decrease of men with metastatic disease or dying from the disease, while mitigating harm.”

Claims (48 extracted, 5 hedged)

As rates of advanced prostate cancer continue a worrisome rise, the American Cancer Society is recommending that most men ages 50 to 69 get screened every other year. asserted
men → continue → rise
Those at higher risk, including Black men and others with close-family histories of the disease, should get the prostate-specific antigen blood test annually. asserted
Those → include → test
Men ages 70 to 74 should discuss with healthcare providers whether the PSA test makes sense for them, based on their health and life expectancy, according to the ACS. uncertain
test → discuss → ACS
The new guidelines, published Thursday in CA: A Cancer Journal for Clinicians, are the latest pendulum swing in screening standards for prostate cancer, which is the second-leading cause of cancer death among men, behind lung cancer. asserted
which → publish → cancer
Dr. William L. Dahut, chief scientific officer of the ACS, said he hoped the new guidelines “would increase screening for men at average risk and ultimately lead to a decrease of men with metastatic disease or dying from the disease, while mitigating harm.” asserted
guidelines → say → harm
In the previous ACS guidelines, men ages 40 to 50 were advised to engage with their doctors in “shared decision-making” about PSA testing, as long as they had at least a decade of life expectancy. asserted
they → advise → expectancy
Repeat testing was based on a PSA-level threshold. asserted
testing → base → threshold
Now, the ACS much more emphatically recommends that men should get the PSA test every other year after they hit age 50. asserted
they → recommend → age
Annual screening starting at age 45 is advised for two higher-risk groups: - Black men, who have higher rates of prostate cancer and are likelier to die from it. - Men who have fathers or brothers diagnosed under age 65 or who have multiple such relatives diagnosed at any age. The PSA blood test can help detect signs of prostate cancer earlier, when it’s generally more susceptible to treatment. asserted
it → start → treatment
There have long been concerns about PSA testing, because it can trigger unnecessary treatment with devastating side effects, and historically, research that it actually improved men’s survival chances was lacking. asserted
it → trigger → chances
Rising cases of advanced prostate cancer The new guidelines were influenced in particular by a major randomized study of PSA testing in Europe that now has over two decades of follow-up and found that screening among middle-aged men did, indeed, lower prostate cancer deaths. asserted
screening → rise → deaths
Given those and other encouraging newer research findings, the authors of the updated ACS guidelines felt they could recommend the test as beneficial with greater confidence and be more specific about which groups should get tested and at what intervals. uncertain
groups → give → intervals
While the rate of death from prostate cancer fell by half over the past three decades, the decline has slowed overall and stabilized among men ages 55 to 69. The Food and Drug Administration approved the PSA test for cancer surveillance in 1986. asserted
Administration → fall → 1986
Following broad use of the test for prostate cancer screening, late-stage prostate cancer diagnoses dropped by more than half and the death rate fell by 7% by the mid-1990s. asserted
rate → follow → mid-1990s
But in the 2000s, various national health authorities became more concerned about overdiagnosis. asserted
authorities → become → overdiagnosis
So they narrowed the categories of men for whom they recommended screening. asserted
they → narrow → whom
In 2012, the highly influential U.S. Preventive Services Task Force flatly recommended against PSA testing for men of any age. asserted
Force → recommend → age
Diagnoses of late-stage disease subsequently began to creep up, leading to concern that lowered testing was a factor and, ultimately, to campaigns to once again broaden testing. asserted
testing → begin → testing
An ACS study last year found that diagnoses of prostate cancer increased by about 3% annually from 2014 to 2021. asserted
diagnoses → find → 2021
Dahut, who was a co-author of the study, said the trend has continued in recent years. asserted
trend → say → years
The study also found that over a decade of data, cases of metastatic prostate cancer increased by about 6% annually in men ages 55 and older. asserted
cases → find → men
At its best, PSA testing can identify early-stage prostate cancer and lead to treatment — surgery and radiation is the standard of care — that stops it from spreading, improving men’s survival. asserted
that → identify → survival
Among men diagnosed with late-stage prostate cancer, only about a third live five more years. asserted
third → diagnose → cancer
However, the PSA test often identifies cancers that won’t cause major sickness or death, at least not in the near term. asserted
that → identify → term
In those cases, men would often be better off receiving ongoing monitoring rather than treatment. asserted
men → receive → monitoring
Many older men die with prostate cancer but not because of it. asserted
men → die → it
That’s a key reason the ACS and other health authorities don’t recommend the test for older men or others who most likely won’t live 10 more years. asserted
who → ’ → men
PSA testing can also produce false positives that lead to unnecessary treatment and anxiety. asserted
that → produce → treatment
And the biopsy needed to diagnose prostate cancer comes with health risks. asserted
biopsy → need → risks
Crucially, surgery and treatment for prostate cancer can cause severe impacts, including sexual dysfunction, urinary incontinence and bowel problems. asserted
surgery → cause → dysfunction
According to Dahut, recent improvements in medical practices have helped mitigate those effects. uncertain
improvements → accord → effects
The previous ACS guidelines, issued in 2010, advised doctors to discuss with middle-aged men and younger seniors whether they’d like to take the PSA test. asserted
they → issue → test
That more flexible dynamic left too many men forgoing the screening, ACS experts felt. asserted
experts → leave → screening
The new guidelines urge doctors to more flatly recommend the test to that age group. asserted
guidelines → urge → group
Promisingly, doctors are better able to differentiate between prostate cancer cases that are serious enough to need immediate treatment and those that are better monitored over time. asserted
that → differentiate → time
“Cancer still prompts a visceral, negative reaction in most people that for the most part is unwarranted in a lot of circumstances,” said Dr. Daniel George, a medical oncologist at Duke Health who specializes in urological cancers. asserted
who → prompt → cancers
George wasn’t involved with the new guidelines. asserted
George → involve → guidelines
“There are more cancer survivors in the United States than ever before in history,” he said. asserted
he → be → history
“That’s only going to increase. asserted
That → go → ?
And that’s not because of overdiagnosis; that’s because of more effective therapies for these patients.” The change in guidelines could, in theory, have caught former President Joe Biden’s cancer earlier. uncertain
change → ’ → cancer
…and 8 more, not listed.
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support